Copertina

Corrigendum to "Degradation of NLRP3 by selective ROCK2 inhibitor alleviates acute lung injury" [Eur. J. Pharmacol. 1004 (2025) 178009].

Fuente: PubMed

Salvato in:

Dettagli Bibliografici
Autori principali:	Zhan, Shuai, Zhang, Ningjing, Lou, Yijie, Ding, Xia, Chen, Zhe, Huang, Yun, Ding, Wanjing
Natura:	Artículo científico
Lingua:	en
Pubblicazione:	European journal of pharmacology 2025
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Degradation of NLRP3 by selective ROCK2 inhibitor alleviates acute lung injury.
di: Zhan, Shuai, et al.
Pubblicazione: (2025)

KHSRP protects colorectal cancer cells against ferroptosis by regulating GPX4 expression through interaction with hnRNPM.
di: Ding, Xia, et al.
Pubblicazione: (2025)

Discovery of the First-in-Class Dual-Target ROCK/HDAC Inhibitor with Potent Antitumor Efficacy in Vivo That Trigger Antitumor Immunity.
di: Mao, Churu, et al.
Pubblicazione: (2024)

Discovery of an orally bioavailable pyridone-based BRD4 inhibitor with potent antitumor efficacy in colorectal cancer.
di: Fang, Zhangyun, et al.
Pubblicazione: (2026)

Design, Synthesis, and Evaluation of a Potent and Selective ROCK2 Inhibitor for Atopic Dermatitis Treatment.
di: Mao, Churu, et al.
Pubblicazione: (2026)

Inhibitory profile and selectivity of novel ROCK 2 inhibitors: an in‐silico study
di: Kimia Mohammadi
Pubblicazione: (2025)

Jatrorrhizine alleviates cytokine storm secondary lung injury via regulating CD39‐dominant purinergic braking and downstream NLRP3 inflammasome
di: Yuejia Lan, et al.
Pubblicazione: (2025)

Retraction: Tanshinone IIA alleviates lipopolysaccharide‐induced acute lung injury by downregulating TRPM7 and pro‐inflammatory factors
Pubblicazione: (2024)

ATG16L1 restrains macrophage NLRP3 activation and alveolar epithelial cell injury during septic lung injury
di: Yan Bai, et al.
Pubblicazione: (2025)

Nerandomilast, a PDE4B inhibitor, alleviates silica‐induced lung inflammation and fibrosis by inhibition of NLRP3 inflammasome and TGF‐β/Smad signalling
di: Yuanying Wang, et al.
Pubblicazione: (2025)

Exploring the anti‐inflammatory ingredients and potential of golden buckwheat ( Fagopyrum dibotrys ) on the TLR4/NLRP3 pathway in acute lung injury
di: Yingfan Hu, et al.
Pubblicazione: (2024)

Pentraxin‐related protein PTX3 alleviates blast‐induced acute lung injury by promoting efferocytosis to eliminate ferroptotic alveolar epithelial cells in vitro
di: Chang‐Mei Weng, et al.
Pubblicazione: (2025)

Physical probes expose and alleviate chemical-environment collapse in molecular representations
di: Fang, Jiebin, et al.
Pubblicazione: (2026)

Hypoxia‐inducible factor prolyl hydroxylase inhibitor alleviates heatstroke‐induced acute kidney injury by activating BNIP3 ‐mediated mitophagy
di: Ling Wang, et al.
Pubblicazione: (2024)

The impact of circulating nucleosomes on inflammation in acute lung injury
di: Saugata Dutta, et al.
Pubblicazione: (2024)

Dihydrocapsaicin suppresses the STING‐mediated accumulation of ROS and NLRP3 inflammasome and alleviates apoptosis after ischemia–reperfusion injury of perforator skin flap
di: Yingying Lai, et al.
Pubblicazione: (2024)

Fortunellin ameliorates LPS‐induced acute lung injury, inflammation, and collagen deposition by restraining the TLR4/NF‐κB/NLRP3 pathway
di: Danjuan Liu, et al.
Pubblicazione: (2024)

Extracellular vesicles derived from M2‐like macrophages alleviate acute lung injury in a miR‐709‐mediated manner
di: Jie Yang, et al.
Pubblicazione: (2024)

Letter to the editor of the Brit J Clin Pharmacol on Hartjes et al. 2025 https://doi.org/10.1002/bcp.70176
di: Rafael Henry‐Venson
Pubblicazione: (2025)

Letter to the editor of the Brit J Clin Pharmacol on Heuberger et al. 2025 https://doi.org/10.1002/bcp.70090
di: Markus Hinder, et al.
Pubblicazione: (2025)

Carnosol alleviates cisplatin–induced acute kidney injury by regulating apoptosis and pyroptosis
di: Chunjie Li, et al.
Pubblicazione: (2024)

Transfusion related acute lung injury: An underdiagnosed and dangerous entity
di: M.A. Ariza-Prota
Pubblicazione: (2017)

Role of biomarkers and molecular signaling pathways in acute lung injury
di: Pakter Niri, et al.
Pubblicazione: (2024)

Potential pharmaceuticals targeting neuroimmune interactions in treating acute lung injury
di: Di Wu, et al.
Pubblicazione: (2024)

The inhibitory impact of Schisandrin on inflammation and oxidative stress alleviates LPS‐induced acute kidney injury
di: Xinyao Liu, et al.
Pubblicazione: (2024)

lncRNA NORAD alleviates dysfunction of renal proximal tubular epithelial cells during the sepsis‐associated acute kidney injury by modulating the miR‐155‐5p‐PDK1 axis
di: Hulin Lu, et al.
Pubblicazione: (2024)

Pirfenidone alleviates smoke inhalation lung injury of rats via the NF‐κB signaling pathway
di: Tingting Lv, et al.
Pubblicazione: (2024)

CASQ2 alleviates lung cancer by inhibiting M2 tumor‐associated macrophage polarization and JAK/STAT pathway
di: Yan Ding, et al.
Pubblicazione: (2024)

Macrophages modulate skeletal muscle wasting and recovery in acute lung injury in mice
di: Jennifer T. W. Krall, et al.
Pubblicazione: (2024)

Transfusion‐associated acute lung injury following albumin treatment in liver disease
di: Hussam Al Hennawi, et al.
Pubblicazione: (2024)

(Table 1) Depths and ages of seismic sequence boundaries in ODP Hole 166-1004
di: Anselmetti, Flavio S, et al.
Pubblicazione: (2000)

Flexible bronchoscopy during mechanical ventilation in the prone position to treat acute lung injury
di: F. Guarracino
Pubblicazione: (2013)

Front Cover: (Eur. J. Inorg. Chem. 18/2025)
Pubblicazione: (2025)

Front Cover: (Eur. J. Org. Chem. 3/2025)
Pubblicazione: (2025)

Front Cover: (Eur. J. Inorg. Chem. 19/2025)
Pubblicazione: (2025)

Front Cover: (Eur. J. Inorg. Chem. 20/2025)
Pubblicazione: (2025)

Ethanol extracts of Isochrysis zhanjiangensis alleviate acute alcoholic liver injury and modulate intestinal bacteria dysbiosis in mice
di: Yangmin Wen, et al.
Pubblicazione: (2024)

L ‐ascorbyl‐2‐phosphate alleviates white matter injury caused by chronic hypoxia through the PRMT5 / P53 / NF‐κB pathway
di: Bingqing Ding, et al.
Pubblicazione: (2024)

Cover Picture: Eur. J. Lipid Sci. Technol. 12/2025
Pubblicazione: (2025)

Cover Picture: Eur. J. Lipid Sci. Technol. 7/2025
Pubblicazione: (2025)